Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4261
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWurzel, D.en
dc.contributor.authorButtery, J.en
dc.contributor.authorCarr, J.en
dc.contributor.authorClark, J. E.en
dc.contributor.authorCheng, A. C.en
dc.contributor.authorDinsmore, N.en
dc.contributor.authorFrancis, J. R.en
dc.contributor.authorKynaston, A.en
dc.contributor.authorLucas, R.en
dc.contributor.authorMarshall, H.en
dc.contributor.authorMcMullan, B.en
dc.contributor.authorSingh-Grewal, D.en
dc.contributor.authorWood, N.en
dc.contributor.authorMacartney, K.en
dc.contributor.authorBritton, P. N.en
dc.contributor.authorCrawford, N. W.en
dc.contributor.authorTosif, S.en
dc.contributor.authorBurgner, D.en
dc.contributor.authorBlyth, C. C.en
dc.contributor.authorHoq, M.en
dc.contributor.authorMcMinn, A.en
dc.date.accessioned2022-11-07T23:50:59Z-
dc.date.available2022-11-07T23:50:59Z-
dc.date.issued2021en
dc.identifier.citation11, (11), 2021en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/4261-
dc.description.abstractObjective To present Australia-wide data on paediatric COVID-19 and multisystem inflammatory syndromes to inform health service provision and vaccination prioritisation. Design Prospective, multicentre cohort study. Setting Eight tertiary paediatric hospitals across six Australian states and territories in an established research surveillance network - Paediatric Active Enhanced Disease (PAEDS). Participants All children aged <19 years with SARS-CoV-2 infection including COVID-19, Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) and Kawasaki-like disease TS infection (KD-TS) treated at a PAEDS site from 24 March 2020 to 31 December 2020. Intervention Laboratory-confirmed SARS-CoV-2 infection. Main outcome Incidence of severe disease among children with COVID-19, PIMS-TS and KD-TS. We also compared KD epidemiology before and during the COVID-19 pandemic. Results Among 386 children with SARS-CoV-2 infection, 381 (98.7%) had COVID-19 (median 6.3 years (IQR 2.1-12.8),53.3% male) and 5 (1.3%) had multisystem inflammatory syndromes (PIMS-TS, n=4; KD-TS, n=1) (median 7.9 years (IQR 7.8-9.8)). Most children with COVID-19 (n=278; 73%) were Australian-born from jurisdictions with highest community transmission. Comorbidities were present in 72 (18.9%); cardiac and respiratory comorbidities were most common (n=32/72;44%). 37 (9.7%) children with COVID-19 were hospitalised, and two (0.5%) required intensive care. Postinfective inflammatory syndromes (PIMS-TS/KD-TS) were uncommon (n=5; 1.3%), all were hospitalised and three (3/5; 60%) required intensive care management. All children recovered and there were no deaths. KD incidence remained stable during the pandemic compared with prepandemic. Conclusions Most children with COVID-19 had mild disease. Severe disease was less frequent than reported in high prevalence settings. Preventative strategies, such as vaccination, including children and adolescents, could reduce both the acute and postinfective manifestations of the disease.L6364192302021-11-25 <br />2021-12-01 <br />en
dc.language.isoenen
dc.relation.ispartofBMJ Openen
dc.titleProspective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: A national cohort studyen
dc.typeArticleen
dc.identifier.doi10.1136/bmjopen-2021-054510en
dc.subject.keywordshumanen
dc.subject.keywordshuman tissueen
dc.subject.keywordsimmunotherapyen
dc.subject.keywordsintensive careen
dc.subject.keywordsinvasive ventilationen
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsmalaiseen
dc.subject.keywordsmaleen
dc.subject.keywordsnasopharyngeal swaben
dc.subject.keywordsnauseaen
dc.subject.keywordsoropharyngeal swaben
dc.subject.keywordspediatric hospitalen
dc.subject.keywordspediatric multisystem inflammatory syndromeen
dc.subject.keywordspediatric patienten
dc.subject.keywordsmulticenter studyen
dc.subject.keywordsprospective studyen
dc.subject.keywordsantibiotic agentcorticosteroiden
dc.subject.keywordsenoxaparinen
dc.subject.keywordsimmunoglobulinen
dc.subject.keywordsinotropic agenten
dc.subject.keywordslow molecular weight heparinen
dc.subject.keywordsremdesiviren
dc.subject.keywordsageusiaen
dc.subject.keywordsanosmiaen
dc.subject.keywordsarticleen
dc.subject.keywordsasymptomatic coronavirus disease 2019en
dc.subject.keywordsAustraliaen
dc.subject.keywordschilden
dc.subject.keywordscohort analysisen
dc.subject.keywordscommon colden
dc.subject.keywordscomorbidityen
dc.subject.keywordscongenital heart diseaseen
dc.subject.keywordscontact examinationen
dc.subject.keywordscontrolled studyen
dc.subject.keywordscoronavirus disease 2019en
dc.subject.keywordscorticosteroid therapyen
dc.subject.keywordscoughingen
dc.subject.keywordsdiarrheaen
dc.subject.keywordsdisease severityen
dc.subject.keywordsextracorporeal oxygenationen
dc.subject.keywordsfatigueen
dc.subject.keywordsfemaleen
dc.subject.keywordsfeveren
dc.subject.keywordsgastrointestinal symptomen
dc.subject.keywordsheadacheen
dc.subject.keywordsheart septum defecten
dc.subject.keywordshigh flow nasal cannula therapyen
dc.subject.keywordshospitalized childen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L636419230&from=exporthttp://dx.doi.org/10.1136/bmjopen-2021-054510 |en
dc.identifier.risid2757en
local.message.claim2024-06-20T09:36:53.866+1000|||rp03979|||submit_approve|||dc_contributor_author|||None*
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

44
checked on Feb 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.